[Effects on polycystic ovary syndrome of abdominal obesity treated with the dialing needling method at the abdomen]

Zhongguo Zhen Jiu. 2018 Dec 12;38(12):1273-6. doi: 10.13703/j.0255-2930.2018.12.006.
[Article in Chinese]

Abstract

Objective: To observe the clinical effects on polycystic ovary syndrome (PCOS) of abdominal obesity treated with the dialing needling technique at the abdomen.

Methods: A total of 33 patients of PCOS of abdominal obesity were treated with the dialing needling method. The reinforcing technique was applied to Zhongwan (CV 12), Qihai (CV 6), Guanyuan (CV 4) and Zhongji (CV 3) and the reducing technique was applied to Huaroumen (ST 24), Tianshu (ST 25), Shuifen (CV9), Luanchaoxue (Extra), Huangshu (KI 16) and Daimai (GB 26). The electric stimulation was added at Huaroumen (ST 24), Tianshu (ST 25) and bilateral Daimai (GB 26). The treatment was given once every two days, three times a week. The treatment was discontinued during the menstruation, 10 treatments made one course. Totally, 6 courses of treatment were provided. The body mass index (BMI) and the ovarian volume were observed before and after treatment. The levels of serum fasting insulin (FINS), fasting blood glucose (FBG), serum follicle stimulating hormone (FSH), luteinizing hormone (LH), testosterone (T) and prolactin (PRL) were determined before and after treatment.

Results: As compared with those before treatment, BMI was reduced obviously (P<0.01), the ovarian volume was shrunk obviously (P<0.01) and the levels of serum FINS, LH and T were reduced obviously (P<0.05, P<0.01) after treatment. The differences in serum PRL and FSH were not significant before and after treatment (both P>0.05).

Conclusion: The dialing needling method reduces the body mass and ovarian volume in the patients of PCOS of abdominal obesity type. The effect mechanism is relevant with the reducing of FNS, LH and T.

Keywords: abdominal obesity; acupuncture therapy; dialing needling method; polycystic ovary syndrome.

MeSH terms

  • Abdomen
  • Acupuncture Therapy*
  • Female
  • Follicle Stimulating Hormone
  • Humans
  • Luteinizing Hormone
  • Obesity
  • Obesity, Abdominal*
  • Polycystic Ovary Syndrome* / therapy

Substances

  • Luteinizing Hormone
  • Follicle Stimulating Hormone